Matthew J. Gartner

509 total citations
13 papers, 299 citations indexed

About

Matthew J. Gartner is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Matthew J. Gartner has authored 13 papers receiving a total of 299 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 7 papers in Virology and 5 papers in Epidemiology. Recurrent topics in Matthew J. Gartner's work include HIV Research and Treatment (7 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and HIV/AIDS Research and Interventions (4 papers). Matthew J. Gartner is often cited by papers focused on HIV Research and Treatment (7 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and HIV/AIDS Research and Interventions (4 papers). Matthew J. Gartner collaborates with scholars based in Australia, United States and Canada. Matthew J. Gartner's co-authors include Michael Roche, Melissa J. Churchill, Paul R. Gorry, Jacqueline K. Flynn, Sharon R. Lewin, Nicholas S. Eyre, Michael R. Beard, Kylie H. Van der Hoek, Jillian M. Carr and Karla J. Helbig and has published in prestigious journals such as Annals of Neurology, Journal of Virology and Scientific Reports.

In The Last Decade

Matthew J. Gartner

13 papers receiving 298 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew J. Gartner Australia 7 167 162 78 60 53 13 299
Diego Ojeda Argentina 11 50 0.3× 97 0.6× 73 0.9× 81 1.4× 80 1.5× 24 302
Nadeene E. Riddick United States 8 220 1.3× 106 0.7× 107 1.4× 66 1.1× 77 1.5× 10 270
Oksana Zakharova United States 8 245 1.5× 192 1.2× 96 1.2× 33 0.6× 69 1.3× 13 334
Sarah Sterrett United States 11 124 0.7× 181 1.1× 126 1.6× 53 0.9× 86 1.6× 15 355
Irma Maurer Netherlands 7 163 1.0× 109 0.7× 60 0.8× 33 0.6× 87 1.6× 15 250
Emily S. Ryan United States 5 246 1.5× 120 0.7× 158 2.0× 22 0.4× 74 1.4× 5 295
Julie Frouard United States 8 61 0.4× 210 1.3× 111 1.4× 59 1.0× 57 1.1× 12 343
George S. Haret-Richter United States 11 263 1.6× 161 1.0× 116 1.5× 55 0.9× 82 1.5× 12 343
Slim Fourati United States 6 81 0.5× 120 0.7× 105 1.3× 66 1.1× 73 1.4× 13 281
Nina Calantone United States 7 205 1.2× 142 0.9× 102 1.3× 124 2.1× 64 1.2× 8 337

Countries citing papers authored by Matthew J. Gartner

Since Specialization
Citations

This map shows the geographic impact of Matthew J. Gartner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew J. Gartner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew J. Gartner more than expected).

Fields of papers citing papers by Matthew J. Gartner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew J. Gartner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew J. Gartner. The network helps show where Matthew J. Gartner may publish in the future.

Co-authorship network of co-authors of Matthew J. Gartner

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew J. Gartner. A scholar is included among the top collaborators of Matthew J. Gartner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew J. Gartner. Matthew J. Gartner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Gartner, Matthew J., Monique L. Smith, Clyde Dapat, et al.. (2025). Contemporary seasonal human coronaviruses display differences in cellular tropism compared to laboratory-adapted reference strains. Journal of Virology. 99(9). e0068425–e0068425. 1 indexed citations
2.
Houghton, Michael J., Églantine Balland, Matthew J. Gartner, et al.. (2024). The flavonoid quercetin decreases ACE2 and TMPRSS2 expression but not SARS‐CoV ‐2 infection in cultured human lung cells. BioFactors. 50(6). 1268–1286. 4 indexed citations
3.
Gartner, Matthew J., Leo Lee, Francesca L. Mordant, et al.. (2023). Ancestral, Delta, and Omicron (BA.1) SARS-CoV-2 strains are dependent on serine proteases for entry throughout the human respiratory tract. Med. 4(12). 944–955.e7. 4 indexed citations
4.
Cochrane, Catherine R., Thomas A. Angelovich, Jingling Zhou, et al.. (2022). Intact HIV Proviruses Persist in the Brain Despite Viral Suppression with ART. Annals of Neurology. 92(4). 532–544. 49 indexed citations
5.
Chen, Qianyu, Shenna Langenbach, Meina Li, et al.. (2022). ACE2 Expression in Organotypic Human Airway Epithelial Cultures and Airway Biopsies. Frontiers in Pharmacology. 13. 813087–813087. 12 indexed citations
6.
Gartner, Matthew J., Carolin Tumpach, Ashanti Dantanarayana, et al.. (2022). Persistence of envelopes in different CD4+ T-cell subsets in antiretroviral therapy-suppressed people with HIV. AIDS. 37(2). 247–257. 2 indexed citations
7.
Zerbato, Jennifer M., Georges Khoury, Wei Zhao, et al.. (2021). Multiply spliced HIV RNA is a predictive measure of virus production ex vivo and in vivo following reversal of HIV latency. EBioMedicine. 65. 103241–103241. 25 indexed citations
8.
Gartner, Matthew J. & Kanta Subbarao. (2021). The threat of zoonotic coronaviruses. Microbiology Australia. 42(1). 4–9. 4 indexed citations
9.
Gartner, Matthew J., Michael Roche, Melissa J. Churchill, Paul R. Gorry, & Jacqueline K. Flynn. (2020). Understanding the mechanisms driving the spread of subtype C HIV-1. EBioMedicine. 53. 102682–102682. 55 indexed citations
10.
Gartner, Matthew J., Paul R. Gorry, Carolin Tumpach, et al.. (2020). Longitudinal analysis of subtype C envelope tropism for memory CD4+ T cell subsets over the first 3 years of untreated HIV-1 infection. Retrovirology. 17(1). 24–24. 2 indexed citations
11.
Anderson, Jenny L., Gabriela Khoury, Rémi Fromentin, et al.. (2019). Human Immunodeficiency Virus (HIV)–Infected CCR6+ Rectal CD4+ T Cells and HIV Persistence On Antiretroviral Therapy. The Journal of Infectious Diseases. 221(5). 744–755. 37 indexed citations
12.
13.
Hoek, Kylie H. Van der, Nicholas S. Eyre, Jillian M. Carr, et al.. (2017). Viperin is an important host restriction factor in control of Zika virus infection. Scientific Reports. 7(1). 4475–4475. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Diego Ojeda Breakdown of academic impact, for papers by Nadeene E. Riddick Breakdown of academic impact, for papers by Oksana Zakharova Breakdown of academic impact, for papers by Sarah Sterrett Breakdown of academic impact, for papers by Irma Maurer Breakdown of academic impact, for papers by Emily S. Ryan Breakdown of academic impact, for papers by Julie Frouard Breakdown of academic impact, for papers by George S. Haret-Richter Breakdown of academic impact, for papers by Slim Fourati Breakdown of academic impact, for papers by Nina Calantone
Rankless by CCL
2026